Tumor lysis syndrome (TLS) is an oncologic emergency from the intracellular release of
material in lysing malignant cells. The earlier it is treated, the less likely it is to be harmful to …

Tumor lysis syndrome (TLS) in patients with solid tumors is a rare and potentially fatal
condition associated with anti-cancer treatment. Its outcome depends on awareness …

No systematic synthesis of all cases of spontaneous tumor lysis syndrome (STLS) in adult
patients with solid tumors is available to date. Herein, we aim to recognize specific STLS …

Tumor lysis syndrome (TLS) is a life-threatening oncologic emergency. It is characterized by
massive tumor cell death leading to metabolic derangements and multiple organ failure. It is …

Introduction: Awareness regarding the etiological spectrum of tetany is poor among
physicians. Because of poor awareness, tetany is underdiagnosed and undertreated …

Tumor lysis syndrome (TLS) occurs when large numbers of tumor cells lyse and release
their contents, causing electrolyte derangements and renal injury. It is an uncommon …

Tumor lysis syndrome (TLS) is a life-threatening emergency that usually develops in rapidly
proliferating hematologic malignancies or advanced solid tumor following cytotoxic …

Tumor lysis syndrome (TLS) is an oncologic emergency that usually occurs after initial
treatment of a malignant tumor. It manifests as hyperuricaemia, hyperkalaemia …

Discussion A still underestimated side effect of TKIs is hypocalcemia, which is potentially life
threatening and defined as a serum calcium level, interpreted in relation to serum albumin …